EligibleTrials

Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)

Recruiting · NCT02246634 · Interventional (participants receive a specific treatment) · Lead sponsor: Imperial College London

View the official record on ClinicalTrials.gov →
Colorectal cancer

Interventions studied

Diffusion Weighted MRI scan

What this trial is about

Eligible patients with high risk colorectal malignancy (T3/4, spread greater than 5mm, EMVI positive) will have additional surveillance of breath hold T1, T2 and DW-MRIs (no IV contrast) post surgery six monthly for three years. Findings of liver MRIs as reported by radiology PI will be shared with their local MDT who make decisions as appropriate, including the management of any identified liver metastases, according to local protocol.

Who can take part

Age range
16 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

13 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.